Executive Summary
Biomanufacturing is becoming increasingly complex.
Producing biologics, vaccines, cell therapies, and other advanced therapies requires precise control of biological processes that can be highly sensitive to changes in raw materials, equipment, environmental conditions, and process parameters.
Digital twins offer a new way to manage this complexity.
A digital twin is a virtual representation of a physical manufacturing process that is continuously informed by real-world data. In biomanufacturing, digital twins can represent bioreactors, production processes, equipment, facilities, and entire manufacturing workflows.
By combining process data, sensors, artificial intelligence, and mechanistic models, digital twins can help manufacturers understand what is happening in a process, predict what could happen next, and evaluate potential interventions before making physical changes.
The opportunity extends beyond operational efficiency. Digital twins could support process development, technology transfer, continuous manufacturing, quality management, predictive maintenance, and regulatory compliance.
For biopharma companies, the long-term goal is a manufacturing environment that is more predictive, adaptive, and resilient.
Why Is Biomanufacturing Well Suited to Digital Twins?
Biological manufacturing processes generate large volumes of data.
Bioreactors and other production systems continuously capture information about variables such as temperature, pH, dissolved oxygen, pressure, agitation, nutrient levels, and other process conditions.
At the same time, relatively small changes in process conditions can affect product quality and yield.
Traditional manufacturing approaches often rely on predefined operating ranges and periodic testing. Digital twins introduce the possibility of continuously analyzing process behavior and simulating how changes could influence outcomes.
This can help manufacturers move from reacting to deviations toward anticipating potential problems.
How Do Digital Twins Work in Biomanufacturing?
A biomanufacturing digital twin connects a virtual process model with data from its physical counterpart.
Sensors and manufacturing systems provide real-time information. The digital model processes that information and represents the current state of the manufacturing process.
AI and advanced analytics can then identify patterns, detect anomalies, or predict future conditions.
Manufacturers can use the digital twin to evaluate different scenarios without immediately changing the physical process.
The overall cycle can be viewed as:
Physical process → Data → Digital twin → Prediction or simulation → Manufacturing decision → New data
As more data becomes available, the model can potentially become more useful and accurate.
How Can Digital Twins Improve Bioprocess Optimization?
Bioprocess optimization often requires balancing numerous variables simultaneously.
A change in one parameter can affect several other aspects of the process. Testing every possible combination physically would be expensive and time-consuming.
Digital twins can provide a virtual environment for exploring these relationships.
Manufacturers could simulate different operating conditions and identify combinations that are more likely to achieve desired outcomes.
Potential applications include:
- Bioreactor optimization
- Cell culture process development
- Yield improvement
- Parameter optimization
- Process scale-up
- Media optimization
- Process robustness assessment
This could reduce the number of physical experiments required during process development and accelerate the identification of optimal conditions.
Can Digital Twins Improve Product Quality?
Quality is one of the strongest potential applications.
Biologics are highly sensitive products, and quality can be influenced by variations throughout the manufacturing process.
Digital twins can integrate process parameters with analytical and quality data to identify relationships between manufacturing conditions and critical quality attributes.
This can help manufacturers better understand which process variables have the greatest influence on product quality.
Instead of discovering a quality issue only after testing a finished batch, manufacturers could potentially identify emerging risks earlier in the process.
The long-term opportunity is to shift from predominantly testing quality after production toward continuously managing the conditions that create quality.
How Can Digital Twins Support Predictive Manufacturing?
Predictive capabilities can help manufacturers anticipate process problems before they become significant disruptions.
A digital twin can monitor process behavior and compare current conditions with historical or expected patterns.
If the model detects an unusual trend, it may identify a potential deviation or equipment problem before it affects the batch.
This could support predictive interventions such as adjusting process parameters, investigating raw-material variability, or scheduling maintenance.
The objective is not simply to detect problems faster. It is to understand why a problem may be developing and determine the most appropriate response.
What Role Does AI Play in Biomanufacturing Digital Twins?
AI can significantly enhance digital twins.
Machine learning models can identify complex relationships across large datasets that may be difficult to capture through traditional process models alone.
AI can support anomaly detection, predictive modeling, process optimization, and decision support.
However, AI and digital twins serve different purposes.
AI can generate predictions and identify patterns, while the digital twin provides a structured representation of the physical manufacturing system in which those predictions can be evaluated.
Combining data-driven AI with mechanistic understanding may therefore be particularly valuable in biomanufacturing.
Can Digital Twins Accelerate Scale-Up and Technology Transfer?
Moving a bioprocess from development to commercial manufacturing can introduce significant uncertainty.
Processes that perform well at laboratory or pilot scale may behave differently at larger scales because of changes in equipment geometry, mixing, heat transfer, oxygen transfer, and other physical conditions.
Digital twins can help manufacturers model these changes before physically scaling the process.
They could also support technology transfer by providing a common digital representation of the process across development and manufacturing environments.
This could improve knowledge transfer and help teams identify potential scale-up challenges earlier.
How Could Digital Twins Support Cell and Gene Therapy Manufacturing?
Advanced therapies create additional manufacturing challenges.
Cell and gene therapy processes can involve complex biological materials, sensitive processing conditions, and highly individualized production workflows.
Digital twins could potentially model aspects of these processes and help teams understand how changes in manufacturing conditions influence outcomes.
For personalized therapies, digital representations could eventually support more adaptive manufacturing strategies.
However, these applications remain challenging. Biological variability, limited datasets, and complex process interactions mean that sophisticated models require extensive validation.
The opportunity is significant, but the technology must mature alongside the underlying manufacturing science.
Can Digital Twins Strengthen GMP Compliance?
Digital twins could also support regulated manufacturing environments.
A well-designed digital representation can connect process data, equipment information, quality attributes, and manufacturing events.
This could improve process understanding and support activities such as continuous process verification, deviation investigation, root-cause analysis, and change assessment.
However, using a digital twin in a GMP environment requires confidence in the model and its data.
Companies will need appropriate validation, version control, data integrity, cybersecurity, and documentation.
Regulatory acceptance will depend on demonstrating that digital models are fit for their intended purpose.
What Are the Biggest Challenges?
Building effective digital twins is not simply a software exercise.
Manufacturers often operate complex environments containing equipment from multiple vendors, legacy systems, disconnected data sources, and different data standards.
Other challenges include:
- Data quality and interoperability
- Model validation
- Cybersecurity
- Integration with manufacturing systems
- High implementation costs
- Organizational capability
- Regulatory expectations
There is also the challenge of biological complexity. A model that works well for one process may not automatically transfer to another.
Companies therefore need to treat digital twins as evolving scientific and operational systems rather than static software products.
How Should Biopharma Companies Start?
The strongest approach is to begin with a focused use case.
Companies could select a high-value process where sufficient data already exists and where improved prediction or optimization could generate measurable benefits.
Manufacturers should establish reliable data infrastructure before attempting to create highly sophisticated digital twins.
They should also bring process scientists, engineers, data scientists, IT teams, quality specialists, and regulatory experts into the initiative from the beginning.
The objective should be measurable business value—not simply creating a digital replica.
What Will the Future of Digital Twins in Biomanufacturing Look Like?
The future could involve increasingly autonomous manufacturing environments.
Digital twins may continuously monitor production, predict process behavior, recommend interventions, and work alongside AI systems to optimize manufacturing conditions.
Over time, multiple digital twins could also become connected across the manufacturing network, linking raw materials, equipment, production processes, quality systems, and supply chain operations.
This could create a digital thread spanning process development through commercial production.
The ultimate goal is a manufacturing environment that learns from every batch and becomes increasingly capable of predicting and preventing problems.
Conclusion
Digital twins could become a foundational technology for the next generation of biomanufacturing.
By connecting real-time manufacturing data with virtual process models, AI, and advanced analytics, they can help manufacturers understand complex biological processes and make more informed decisions.
Their potential extends across process optimization, quality management, predictive maintenance, scale-up, technology transfer, and GMP operations.
The challenges are substantial. Data fragmentation, model validation, biological complexity, cybersecurity, and regulatory requirements must all be addressed.
But the direction is increasingly clear.
Biomanufacturing is moving toward a model in which physical production and digital intelligence operate together. Digital twins could provide the bridge between the two, helping biopharma companies make manufacturing more predictable, efficient, resilient, and responsive.
Biomanufacturing is increasingly adopting digital twin technology to improve production, process control, and operational decision-making. Digital twins create virtual representations of physical manufacturing systems, allowing companies to monitor processes, simulate changes, and identify potential problems before they affect production.
In modern Biomanufacturing, these virtual models can combine information from sensors, manufacturing equipment, laboratory systems, historical production records, and process analytics. This creates a more detailed picture of how biological production processes behave under different conditions.
How Digital Twins Support Biomanufacturing
Digital twins can help Biomanufacturing organizations understand complex production processes in real time. Instead of relying only on historical data, manufacturers can use continuously updated information to monitor equipment performance and process conditions.
